Cover Image
市場調查報告書

Arbor Pharmaceuticals, LLC.:產品平台分析

Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 314852
出版日期 內容資訊 英文 18 Pages
訂單完成後即時交付
價格
Back to Top
Arbor Pharmaceuticals, LLC.:產品平台分析 Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015
出版日期: 2015年05月13日 內容資訊: 英文 18 Pages
簡介

Arbor Pharmaceuticals, LLC. 是專門開發及產品化、提供後期階段產品技術的製藥公司。該公司網羅廣泛的治療領域,經手心臟學、小兒科、神經學、其他處方藥等。

本報告提供Arbor Pharmaceuticals, LLC.產品平台分析的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Arbor Pharmaceuticals, LLC.的基本資料

  • Arbor Pharmaceuticals, LLC.概要
  • 主要資訊
  • 企業資料

Arbor Pharmaceuticals, LLC.:R&D概要

  • 主要的治療範圍

Arbor Pharmaceuticals, LLC.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Arbor Pharmaceuticals, LLC.:開發中產品概況

  • 最後階段的開發中產品
    • 登記前的產品/聯合治療模式
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式

Arbor Pharmaceuticals, LLC.:藥物簡介

  • AR-05
  • AR-01
  • AR-08
  • AR-06

Arbor Pharmaceuticals, LLC.:開發平台分析

  • 各給藥途徑

Arbor Pharmaceuticals, LLC.:最近的開發平台趨勢

Arbor Pharmaceuticals, LLC.:暫停中的計劃

Arbor Pharmaceuticals, LLC.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07083CDB

Summary

Global Markets Direct's, 'Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015', provides an overview of the Arbor Pharmaceuticals, LLC.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Arbor Pharmaceuticals, LLC. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Arbor Pharmaceuticals, LLC.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Arbor Pharmaceuticals, LLC.'s pipeline products

Reasons to buy

  • Evaluate Arbor Pharmaceuticals, LLC.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Arbor Pharmaceuticals, LLC. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Arbor Pharmaceuticals, LLC.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Arbor Pharmaceuticals, LLC. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arbor Pharmaceuticals, LLC.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Arbor Pharmaceuticals, LLC. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Arbor Pharmaceuticals, LLC. Snapshot
    • Arbor Pharmaceuticals, LLC. Overview
    • Key Information
    • Key Facts
  • Arbor Pharmaceuticals, LLC. - Research and Development Overview
    • Key Therapeutic Areas
  • Arbor Pharmaceuticals, LLC. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Arbor Pharmaceuticals, LLC. - Pipeline Products Glance
    • Arbor Pharmaceuticals, LLC. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Arbor Pharmaceuticals, LLC. - Drug Profiles
      c
    • AR-08
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-06
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-18
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Arbor Pharmaceuticals, LLC. - Pipeline Analysis
    • Arbor Pharmaceuticals, LLC. - Pipeline Products by Route of Administration
  • Arbor Pharmaceuticals, LLC. - Recent Pipeline Updates
  • Arbor Pharmaceuticals, LLC. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Arbor Pharmaceuticals, LLC., Key Information
  • Arbor Pharmaceuticals, LLC., Key Facts
  • Arbor Pharmaceuticals, LLC. - Pipeline by Indication, 2015
  • Arbor Pharmaceuticals, LLC. - Pipeline by Stage of Development, 2015
  • Arbor Pharmaceuticals, LLC. - Monotherapy Products in Pipeline, 2015
  • Arbor Pharmaceuticals, LLC. - Phase II, 2015
  • Arbor Pharmaceuticals, LLC. - Phase I, 2015
  • Arbor Pharmaceuticals, LLC. - Pipeline by Route of Administration, 2015
  • Arbor Pharmaceuticals, LLC. - Recent Pipeline Updates, 2015

List of Figures

  • Arbor Pharmaceuticals, LLC. - Pipeline by Top 10 Indication, 2015
  • Arbor Pharmaceuticals, LLC. - Pipeline by Stage of Development, 2015
  • Arbor Pharmaceuticals, LLC. - Monotherapy Products in Pipeline, 2015
Back to Top